Lineage Cell Therapeutics, Inc. · AMEX:LCTX

BlackRock, Inc. reported a 5.00% stake in Lineage Cell Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed Apr 24, 2025

BlackRock, Inc. reported a 5.00% stake in Lineage Cell Therapeutics, Inc., 11,453,305 shares, as a passive investor on Mar 31, 2025. Filed Apr 24, 2025 (Schedule 13G).

Stake
5.00%
Shares
11,453,305
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.00%11,453,305

Source

View original at SEC

Related